859 related articles for article (PubMed ID: 16010208)
1. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
2. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
3. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.
Fernandez C; Bardin N; De Paula AM; Salort-Campana E; Benyamine A; Franques J; Schleinitz N; Weiller PJ; Pouget J; Pellissier JF; Figarella-Branger D
Medicine (Baltimore); 2013 Jan; 92(1):15-24. PubMed ID: 23269233
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
[TBL] [Abstract][Full Text] [Related]
5. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.
Váncsa A; Gergely L; Ponyi A; Lakos G; Németh J; Szodoray P; Dankó K
Joint Bone Spine; 2010 Mar; 77(2):125-30. PubMed ID: 20188618
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of idiopathic inflammatory myopathies in South Africa.
Chinniah KJ; Mody GM
Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
[TBL] [Abstract][Full Text] [Related]
7. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
8. Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Uthman I; Vázquez-Abad D; Senécal JL
Semin Arthritis Rheum; 1996 Aug; 26(1):447-58. PubMed ID: 8870112
[TBL] [Abstract][Full Text] [Related]
9. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
[TBL] [Abstract][Full Text] [Related]
10. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
11. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
12. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
13. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
14. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
[TBL] [Abstract][Full Text] [Related]
15. [Myositis-specific autoantibodies].
Gran JT; Molberg Ø; Dobloug GC; Andersson H; Taraldsrud E; Scheie D
Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1631-4. PubMed ID: 19721478
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity in polymyositis/dermatomyositis.
Targoff IN
J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
[TBL] [Abstract][Full Text] [Related]
18. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort.
Naveen R; Rathore U; Agarwal V; Gupta L
Rheumatol Int; 2021 Mar; 41(3):551-563. PubMed ID: 33423071
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.
Pinto B; Janardana R; Nadig R; Mahadevan A; Bhatt AS; Raj JM; Shobha V
Clin Rheumatol; 2019 Jul; 38(7):1931-1934. PubMed ID: 30903308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
